Hearing:
“Office of National Drug Control Policy: Reauthorization in the 115th Congress"
Committee on Oversight and Government Reform
Wednesday, July 26, 2017 (10:30 AM)
Meeting was rescheduled to the time and date listed above.
1100 LHOB
Washington, D.C.
Witnesses
Mr. Richard Baum
Acting Director, Office of National Drug Control Policy
Added
08/07/2017 at 03:08 PM
- Baum Statement
[PDF]
Added
08/07/2017 at 03:08 PM
Mr. Don Flattery
Addiction Policy Advocate and Impacted Parent
Added
08/07/2017 at 03:08 PM
- Flattery Statement
[PDF]
Added
08/07/2017 at 03:08 PM
- Flattery Truth in Testimony
[PDF]
Added
08/07/2017 at 03:08 PM
Dr. Keith Humphreys Ph.D.
Professor of Psychiatry and Behavioral Sciences, Stanford University
Added
08/07/2017 at 03:08 PM
- Humphreys Statement
[PDF]
Added
08/07/2017 at 03:08 PM
- Humphreys Truth in Testimony
[PDF]
Added
08/07/2017 at 03:08 PM
- Humphreys Biography
[PDF]
Added
08/07/2017 at 03:08 PM
Ms. Diana Maurer
Director of Justice and Law Enforcement Issues, U.S. Government Accountability Office
Added
08/07/2017 at 03:08 PM
- Maurer Statement
[PDF]
Added
08/07/2017 at 03:08 PM
- Maurer Biography
[PDF]
Added
08/07/2017 at 03:08 PM
Hearing Record
- 2017-07-26 Office of National Drug Control Policy Reauthorization in the 115th Congress
[PDF]
Added
02/21/2018 at 01:22 PM
First Published:
July 20, 2017 at 09:28 AM
Last Updated:
February 21, 2018 at 01:22 PM